Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Endo Pharmaceuticals Inc patents

Recent patent applications related to Endo Pharmaceuticals Inc. Endo Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Endo Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Endo Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "E" | Endo Pharmaceuticals Inc-related inventors

Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment

The invention pertains to a method of using oxymorphone in the treatment of pain by providing a patient with an oxymorphone dosage form and informing the patient or prescribing physician that the bioavailability of oxymorphone is increased in patients with renal impairment.. . ... Endo Pharmaceuticals Inc

Sustained release formulation of nalbuphine

Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.. . ... Endo Pharmaceuticals Inc

Crystalline, anhydrous forms of oxymorphone hydrochloride

Crystalline, anhydrous hydrochloride salts of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one (oxymorphone) are disclosed and three polymorphic forms of these salts are reported. The invention further relates to a method for the production of such salts, a pharmaceutical composition comprising an effective amount of such a salt as a medicament and for the treatment and/or prevention of pain.. ... Endo Pharmaceuticals Inc

Compositions and methods for treating precocious puberty

The present invention is directed to the controlled delivery of gonadotropin-releasing hormone (gnrh) agonists, preferably from a polymeric material that is implanted in the body. More specifically, the present invention relates to compositions comprised of a gnrh agonist, preferably histrelin, in a polymeric material that results in a desired and controlled delivery of a therapeutically effective amount of gnrh agonist over an extended period of time in order to treat central precocious puberty (cpp).. ... Endo Pharmaceuticals Inc

Controlled release formulations of octreotide

A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing igf-1, and treating conditions associated with carcinoid tumors and vipomas by administering a controlled release formulation of octreotide are provided herein.. ... Endo Pharmaceuticals Inc

Delivery of dry formulations of octreotide

Methods and devices are described for delivering octreotide to a patient, comprising implanting a controlled release composition for delivering octreotide, wherein the composition does not require hydration prior to implantation, and wherein the composition optionally comprises a release agent.. . ... Endo Pharmaceuticals Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Endo Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Endo Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by